Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microneedling Versus Fractional CO₂ Laser Resurfacing for Skin Rejuvenation With Adipose-derived Mesenchymal Stem Cells Secretome: a Single-blind, Randomized Clinical Trial

NCT05508191 is registered in ClinicalTrials.gov with Shannaz Nadia Yusharyahya as lead sponsor.

NCT NCT05508191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05508191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microneedling Versus Fractional CO₂ Laser Resurfacing for Skin Rejuvenation With Adipose-derived Mesenchymal Stem Cells Secretome: a Single-blind, Randomized Clinical Trial
Lead sponsor
Shannaz Nadia Yusharyahya
Phase
Not applicable
Overall status
Completed
Start date
August 17, 2022
Completion date
December 31, 2022
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin aging, transepidermal water loss